Cutera Inc. (CUTR)

40.75
0.40 0.97
NASDAQ : Health Technology
Prev Close 41.15
Open 41.20
Day Low/High 40.51 / 41.60
52 Wk Low/High 20.05 / 56.05
Volume 249.40K
Avg Volume 217.60K
Exchange NASDAQ
Shares Outstanding 13.63M
Market Cap 517.41M
EPS 2.20
P/E Ratio 19.23
Div & Yield N.A. (N.A)
See How Cutera Ranks Among Analysts' Top Picks With Strong Buyback Activity

See How Cutera Ranks Among Analysts' Top Picks With Strong Buyback Activity

A study of analyst recommendations at the major brokerages shows that Cutera Inc is the #4 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

Cutera Enters Oversold Territory (CUTR)

Cutera Enters Oversold Territory (CUTR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cutera Reports Third Quarter 2015 Results

Cutera Reports Third Quarter 2015 Results

Fifth Consecutive Quarter of Double-Digit Revenue Growth

Cutera Enters Oversold Territory (CUTR)

Cutera Enters Oversold Territory (CUTR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cutera Reports Second Quarter 2015 Results

Cutera Reports Second Quarter 2015 Results

Revenue Grew 27%- Fourth Consecutive Quarter of Double-Digit Growth

Short Interest Moves 265.8% Higher For CUTR

Short Interest Moves 265.8% Higher For CUTR

The most recent short interest data has been released by the NASDAQ for the 07/15/2015 settlement date, which shows a 332,022 share increase in total short interest for Cutera Inc , to 456,944, an increase of 265.78% since 06/30/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Cutera (CUTR) Is Strong On High Volume Today

Cutera (CUTR) Is Strong On High Volume Today

Trade-Ideas LLC identified Cutera (CUTR) as a strong on high relative volume candidate

Insider Trading Alert - RAVN, GAIN And CUTR Traded By Insiders

Insider Trading Alert - RAVN, GAIN And CUTR Traded By Insiders

Stocks with insider trader activity include RAVN, GAIN and CUTR

Cutera Reports First Quarter 2015 Results

Cutera Reports First Quarter 2015 Results

Revenue Grew 18% - Driven by Sales of New Products

Cutera Reports Fourth Quarter 2014 Results

Cutera Reports Fourth Quarter 2014 Results

U.S. Revenue Grew 33%, Compared to Prior Year, Driven by Sales of enlighten(TM) and excel HR(TM)

Cutera Announces Preliminary Revenue For Fourth Quarter 2014

Cutera Announces Preliminary Revenue For Fourth Quarter 2014

Company Announces Conferences it Will be Attending in January 2015

Cutera Commences Shipments Of Enlighten(TM)

Cutera Commences Shipments Of Enlighten(TM)

Customer Shipments Start for the First and Only High-Powered, Dual Wavelength and Dual Pulse Duration Laser Featuring Picosecond Technology

Cutera Receives FDA 510(k) Clearance For Tattoo Removal For Enlighten(TM)

Cutera Receives FDA 510(k) Clearance For Tattoo Removal For Enlighten(TM)

The First and Only High-Powered, Dual Wavelength and Dual Pulse Duration Laser Featuring Picosecond Technology-Now Cleared for Tattoo Removal as Well as Benign Pigmented Lesions

Profit From the Longer Life Spans, Part 2

The trend is global, and the investment opportunities extend beyond health-care companies.

Cutera Receives FDA 510(k) Clearance For Enlighten(TM)

Cutera Receives FDA 510(k) Clearance For Enlighten(TM)

First and Only FDA-Cleared Dual Wavelength and Dual Pulse Duration Laser Featuring Picosecond Technology

TheStreet Quant Rating: C+ (Hold)